Söndag 22 December | 02:14:27 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-11-20 08:30 Kvartalsrapport 2025-Q3
2025-08-21 08:30 Kvartalsrapport 2025-Q2
2025-05-22 N/A Årsstämma
2025-05-22 08:30 Kvartalsrapport 2025-Q1
2025-02-20 17:30 Bokslutskommuniké 2024
2024-11-21 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning DIGN 0.00 SEK
2024-05-23 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-12 - Extra Bolagsstämma 2024
2024-02-15 - Bokslutskommuniké 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning DIGN 0.00 SEK
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning DIGN 0.00 SEK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-18 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning DIGN 0.00 SEK
2021-05-20 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2021-01-11 - Extra Bolagsstämma 2021
2020-11-19 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-06-26 - X-dag ordinarie utdelning DIGN 0.00 SEK
2020-06-25 - Årsstämma
2020-05-28 - Kvartalsrapport 2020-Q1
2020-02-25 - Bokslutskommuniké 2019
2020-02-10 - Extra Bolagsstämma 2019
2019-11-19 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-16 - Kvartalsrapport 2019-Q1
2019-05-16 - X-dag ordinarie utdelning DIGN 0.00 SEK
2019-05-15 - Årsstämma
2019-02-26 - Bokslutskommuniké 2018
2018-11-27 - Kvartalsrapport 2018-Q3
2018-08-21 - Kvartalsrapport 2018-Q2
2018-05-22 - Kvartalsrapport 2018-Q1
2018-04-27 - X-dag ordinarie utdelning DIGN 0.00 SEK
2018-04-26 - Årsstämma
2018-02-22 - Bokslutskommuniké 2017
2017-12-04 - Extra Bolagsstämma 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-02 - Årsstämma
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-25 - Kvartalsrapport 2016-Q1
2016-03-23 - X-dag ordinarie utdelning DIGN 0.00 SEK
2016-03-22 - Årsstämma
2016-02-24 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-27 - Kvartalsrapport 2015-Q1
2015-05-19 - X-dag ordinarie utdelning DIGN 0.00 SEK
2015-02-24 - Bokslutskommuniké 2014
2014-11-25 - Kvartalsrapport 2014-Q3
2014-08-26 - Kvartalsrapport 2014-Q2
2014-05-20 - Kvartalsrapport 2014-Q1
2014-05-19 - X-dag ordinarie utdelning DIGN 0.00 SEK
2014-05-16 - Årsstämma
2014-03-04 - Extra Bolagsstämma 2014
2014-02-27 - Bokslutskommuniké 2013
2013-11-28 - Kvartalsrapport 2013-Q3
2013-08-28 - Extra Bolagsstämma 2013
2013-08-28 - Kvartalsrapport 2013-Q2
2013-05-22 - Kvartalsrapport 2013-Q1
2013-05-22 - X-dag ordinarie utdelning DIGN 0.00 SEK
2013-05-21 - Årsstämma
2013-02-27 - Bokslutskommuniké 2012
2012-11-28 - Kvartalsrapport 2012-Q3
2012-10-30 - Extra Bolagsstämma 2012
2012-09-28 - Kapitalmarknadsdag 2012
2012-08-28 - Kvartalsrapport 2012-Q2
2012-06-29 - Årsstämma
2012-05-28 - Kvartalsrapport 2012-Q1
2012-02-27 - Bokslutskommuniké 2011
2011-11-17 - Kvartalsrapport 2011-Q3
2011-08-22 - Kvartalsrapport 2011-Q2
2011-06-13 - X-dag ordinarie utdelning DIGN 0.00 SEK
2011-06-10 - Årsstämma
2011-05-30 - Kvartalsrapport 2011-Q1
2011-02-25 - Bokslutskommuniké 2010
2010-11-18 - Kvartalsrapport 2010-Q3
2010-08-19 - Kvartalsrapport 2010-Q2
2010-06-21 - X-dag ordinarie utdelning DIGN 0.00 SEK
2010-05-18 - Kvartalsrapport 2010-Q1
2010-02-18 - Bokslutskommuniké 2009
2009-12-21 - Split DIGN 100:1
2009-11-18 - Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Dignitana är verksamt inom medicinteknik. Bolaget utvecklar, tillverkar och marknadsför medicinska hjälpmedel som primärt används som skalpkylningssystem vid cytostatikabehandling, vars syfte är att eliminera eller kraftigt reducera håravfall. Bolaget har global verksamhet främst inom Norden, Europa, Nordamerika och Asien. Dignitana grundades år 2007 och har sitt huvudkontor i Lund.
2024-05-23 15:07:09

The following resolutions were passed at the Annual General Meeting (the "AGM") of Dignitana AB (publ) (the "Company") on 23 May 2024 in Malmö.

Adoption of income statement and balance sheet and discharge from liability

The AGM resolved to adopt the income statement for the financial year 2023 as well as the balance sheet and consolidated balance sheet as of 31 December 2023. The members of the Board of Directors and the managing director were discharged from liability for the financial year 2023.

Allocation of profit or loss

The AGM resolved, in accordance with the Board of Directors' proposal, that no dividend shall be paid for 2023 and that the results of the Company shall be carried forward.

Board of Directors and auditor

The AGM resolved, in accordance with the Nomination Committee's proposal, on re-election of Klas Arildsson, William Cronin, Richard DiIorio and Lina Karlsson and election of Fredrik Lindgren and Hope S. Rugo as Board Members. Klas Arildsson was re-elected as the Chairman of the Board of Directors. The AGM re-elected the audit firm Öhrlings PricewaterhouseCoopers AB as auditor.

The AGM further resolved on remuneration to the Board of Directors in accordance with the Nomination Committee's proposal. The AGM furthermore resolved in accordance with the Nomination Committee's proposal, that remuneration to the auditor shall be paid in accordance with approved statement of costs.

Nomination Committee for the next Annual General Meeting

The AGM resolved, in accordance with the Nomination Committee's proposal, that the principles for the appointment of the Nomination Committee adopted at the Annual General Meeting held in 2023 shall continue to apply also for the appointment of the Nomination Committee ahead of the Annual General Meeting to be held in 2025.

Authorization to issue new shares, warrants or convertibles

The AGM resolved to authorize the Board of Directors to on one or several occasions during the period up to the next AGM resolve on new issues of shares, warrants or convertibles with pre-emption rights for the shareholders. Payment may be made in cash, through set-off, with capital contributed in kind, or otherwise as per conditions pursuant to Chapter 2, section 5, second paragraph, items 1-3 and 5 of the Swedish Companies Act. The total number of shares that may be issued, or, in the event of an issue of warrants or convertibles, any additional shares after conversion or exercise of any warrant, pursuant to the authorization shall be limited to 10 percent of the outstanding shares as per the date of the notice for the AGM.

Furthermore, the AGM resolved to authorize the Board of Directors to on one or several occasions during the period up to the next AGM resolve on new issues of shares, warrants or convertibles with deviation from shareholders' pre-emption rights. Payment may be made in cash, through set-off, with capital contributed in kind, or otherwise as per conditions pursuant to Chapter 2, section 5, second paragraph, items 1-3 and 5 of the Swedish Companies Act. The total number of shares that may be issued, or in the event of an issue of warrants or convertibles, any additional shares after conversion or exercise of any warrant, pursuant to the authorization shall be limited to 10 percent of the outstanding shares as per the date of the notice for the AGM. A new issue adopted in virtue of the authorization, shall be carried out with a view to broadening the ownership, procuring or facilitating the procurement of working capital and/or making company acquisitions, or procuring or facilitating the procurement of capital for company acquisitions and/or broadening the ownership of the Company.